Adamax vs Semax

Adamax wins for potency, duration of action, and neurogenesis (thanks to adamantane modification), with once-daily dosing and superior BBB penetration. Stronger, more chronic-drive effect for research targeting neuroplasticity or recovery.
Semax wins for established human data, gentler onset, easier sourcing, and rapid effects. Ideal for short bursts of focus, mood modulation, and cognitive lift with minimal side effect risk.

Pick Adamax if:

• Maximizing neurotrophic/cognitive outcomes over a 4–8 week protocol is the primary goal
• Longer half-life and once-daily dosing is preferred over repeated nasal sprays
• Protocol needs more robust TrkB/BDNF signaling (e.g., brain injury, long-haul neural recovery models)
• Combining with advanced nootropics like P21/Dihexa/Cerebrolysin
• Willing to deal with more limited sourcing and more careful titration

Pick Semax if:

• Rapid-onset cognitive focus/mood support for acute tasks is the goal
• Prefer extensive safety track record and wide peer community documentation
• Need minimal side effect risk and easy, scalable dosing (intranasal)
• Supporting cycle-related mood/irritability in a targeted manner (on/off-cycle protocols)
• Sourcing reliability and simplicity is important; base molecule is sufficient for protocol designs